We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+4.26%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.92B
AUM Growth
+$1.77B
Cap. Flow
+$1.61B
Cap. Flow %
27.24%
Top 10 Hldgs %
29.35%
Holding
6,215
New
374
Increased
3,547
Reduced
1,424
Closed
549

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$87.5M
2
AAPL icon
Apple
AAPL
+$68.6M
3
AMZN icon
Amazon
AMZN
+$62.8M
4
META icon
Meta Platforms (Facebook)
META
+$41.4M
5
AMD icon
Advanced Micro Devices
AMD
+$39.4M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$158M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$70.2M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$34.4M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$33.9M
5
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$22.9M

Sector Composition

Rank Sector Weight
1 Technology 29.49%
2 Consumer Discretionary 9.8%
3 Financials 9.15%
4 Healthcare 9.12%
5 Communication Services 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OMGA
3626
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$24.9K ﹤0.01%
12,019
+6,884
+134% +$16.2K
JILL icon
3627
J. Jill
JILL
$277M
$24.8K ﹤0.01%
708
-2,654
-79% -$81.3K
KGC icon
3628
Kinross Gold
KGC
$32.7B
$24.8K ﹤0.01%
2,975
-36,620
-92% -$265K
MGTX icon
3629
MeiraGTx Holdings
MGTX
$1.2B
$24.7K ﹤0.01%
5,876
+5,379
+1,082% +$27.1K
PMTS icon
3630
CPI Card Group
PMTS
$355M
$24.7K ﹤0.01%
907
+41
+5% +$926
TCRX icon
3631
TScan Therapeutics
TCRX
$50M
$24.7K ﹤0.01%
+4,224
New +$33.3K
VUZI icon
3632
Vuzix
VUZI
$220M
$24.7K ﹤0.01%
18,278
+15,141
+483% +$20.9K
OPI
3633
DELISTED
Office Properties Income Trust
OPI
$24.6K ﹤0.01%
12,082
+10,991
+1,007% +$23.9K
MSGS icon
3634
Madison Square Garden
MSGS
$9.94B
$24.6K ﹤0.01%
131
-166
-56% -$30.8K
DOX icon
3635
Amdocs
DOX
$6.05B
$24.6K ﹤0.01%
312
-7,094
-96% -$583K
QURE icon
3636
uniQure
QURE
$3.14B
$24.6K ﹤0.01%
5,490
-7,678
-58% -$37.4K
PNRG icon
3637
PrimeEnergy Resources
PNRG
$309M
$24.6K ﹤0.01%
231
+134
+138% +$14.1K
KG
3638
Kestrel Group
KG
$69.2M
$24.6K ﹤0.01%
596
+461
+341% +$19.5K
OPTN
3639
DELISTED
OptiNose
OPTN
$24.5K ﹤0.01%
1,572
+1,208
+332% +$20.2K
DGRW icon
3640
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.3B
$24.5K ﹤0.01%
314
-3,957
-93% -$299K
BCAB icon
3641
BioAtla
BCAB
$5.59M
$24.5K ﹤0.01%
357
+327
+1,090% +$38.9K
CGC
3642
Canopy Growth
CGC
$426M
$24.5K ﹤0.01%
3,795
-3,179
-46% -$27.3K
CARM
3643
DELISTED
Carisma Therapeutics
CARM
$24.5K ﹤0.01%
16,087
+5,800
+56% +$8.65K
METCB icon
3644
Ramaco Resources Class B
METCB
$394M
$24.4K ﹤0.01%
2,428
-5,268
-68% -$55.1K
BBVA icon
3645
Banco Bilbao Vizcaya Argentaria
BBVA
$157B
$24.4K ﹤0.01%
2,437
+440
+22% +$4.72K
AFRI icon
3646
Forafric Global
AFRI
$293M
$24.4K ﹤0.01%
2,288
+1,015
+80% +$10.8K
SHCO
3647
DELISTED
Soho House & Co
SHCO
$24.4K ﹤0.01%
4,597
+2,731
+146% +$14.6K
STEM icon
3648
Stem
STEM
$51.1M
$24.3K ﹤0.01%
1,096
+466
+74% +$13.7K
NVDQ icon
3649
T-Rex 2X Inverse NVIDIA Daily Target ETF
NVDQ
$13.8M
$24.3K ﹤0.01%
+201
New +$44.3K
VIG icon
3650
Vanguard Dividend Appreciation ETF
VIG
$115B
$24.3K ﹤0.01%
+133
New +$23.9K
144 145
146
147 148

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2024 Portfolio in Review

As of Q2 2024, Tower Research Capital (TRC) held 6,215 positions worth $5.92B, up 43% from $4.15B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $1.61B of net new capital in Q2 2024, opening 374 new positions and adding to 3,547 existing holdings. Its largest new stake was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $158M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2024 buy was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.
  • Tower Research Capital (TRC) added most to Microsoft in Q2 2024, an estimated $87.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $158M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Mid-Cap ETF in Q2 2024, selling an estimated $18.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $5.92B portfolio in Q2 2024.
  • Tower Research Capital (TRC) opened 374 new positions and closed 549 in Q2 2024.
  • Tower Research Capital (TRC)'s portfolio value rose 43% quarter-over-quarter to $5.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.